On 15 June 2026, Health and Social Care Secretary James Murray toured the radiology department of Wythenshawe Hospital in South Manchester. The visit followed the hospital’s use of the Harrison AI chest‑X‑ray system, which helped diagnose a patient’s rare inflammatory disease within two weeks. During the tour, Murray announced a near £30 million investment in artificial intelligence across the National Health Service.

The announcement came after Murray met Peter Allinson, a 59‑year‑old retired engineer from Urmston, who said the AI‑supported diagnosis had “given him his life back”. Allinson had experienced breathing difficulties and vision problems after a hike in the Peak District. He was referred to the Eye Hospital and then to Wythenshawe, where an X‑ray was taken and analysed by the Harrison AI system. The tool identified signs of sarcoidosis—a non‑cancerous inflammatory condition that can affect the lungs, eyes and other organs—prompting immediate treatment.

Dr Anna Sharman, Consultant Thoracic Radiologist at Wythenshawe, explained that the AI system was used alongside clinical expertise to review the X‑ray quickly and identify the cause of Allinson’s symptoms. She said the technology “acts as a valuable second set of eyes, helping us to prioritise patients and spot a wide range of conditions earlier.” Allinson’s case illustrates the system’s ability to accelerate diagnosis and reduce uncertainty for patients.

The Harrison AI chest‑X‑ray solution was rolled out across Greater Manchester in November 2024. Seven NHS trusts in the region adopted the technology as part of a partnership between the Greater Manchester Cancer Alliance, the Greater Manchester Imaging Network and the global health‑tech firm Harrison.ai. Since its introduction, the system has supported the analysis of thousands of X‑rays each month at Wythenshawe.

Murray’s £30 million pledge is part of a broader NHS strategy to integrate AI tools that can improve diagnostic speed and accuracy. The Health Secretary described AI tools as a “second pair of eyes” for radiologists, emphasising that they are intended to augment, not replace, human judgement. The investment will fund further development of AI diagnostic platforms, training for staff, and the expansion of existing systems like Harrison.ai.

The patient’s experience underscores the potential benefits of AI in clinical settings. Allinson recounted that he had feared lung cancer after his symptoms began, but the rapid diagnosis and treatment allowed him to resume activities such as tennis. He said, “Thanks to the treatment, I’ve been able to get back to doing the things I love… I truly feel like I’ve been given my life back.”

The use of AI in radiology is gaining traction across the UK. Other hospitals have reported similar improvements in turnaround times and diagnostic confidence after adopting AI‑assisted imaging tools. The Greater Manchester rollout is one of the largest coordinated implementations of an AI chest‑X‑ray system in the country.

In conclusion, the visit to Wythenshawe Hospital highlighted how AI can accelerate diagnosis of complex conditions like sarcoidosis and improve patient outcomes. The Health Secretary’s investment will extend these capabilities across the NHS, supporting the deployment of AI tools that act as a second set of eyes for clinicians. The partnership between Greater Manchester trusts and Harrison.ai demonstrates a scalable model for integrating AI into routine imaging workflows.

The current situation is that the NHS is expanding AI diagnostics, with the next steps including further funding, training, and evaluation of outcomes across additional trusts. The impact on patient care, workflow efficiency, and diagnostic accuracy will be monitored as the technology is adopted more widely.